You are viewing the site in preview mode
Skip to main content
| |
Total (N = 844)
|
D5W (n = 365)
|
Saline (n = 479)
|
p value
|
|---|
|
Observation period, days
|
3.99 (2.87–6.80)
|
3.89 (2.88–6.44)
|
4.13 (2.86–7.00)
|
0.233
|
|
Continuous infusion
|
|
Saline, mL
|
4 (0–145)
|
0 (0–126)
|
27 (0–164)
|
0.009
|
|
D5W, mL
|
254 (50–608)
|
257 (68–557)
|
253 (42–634)
|
0.851
|
|
Other crystalloids, mL
|
2492 (1506–3586)
|
2525 (1658–3620)
|
2430 (1359–3568)
|
0.427
|
|
Intermittent infusion
|
|
Saline, mL
|
650 (150–1326)
|
150 (0–450)
|
1000 (650–1750)
|
< 0.001
|
|
D5W, mL
|
387 (0–916)
|
800 (535–1365)
|
0 (0–250)
|
< 0.001
|
|
Other crystalloids, mL
|
0 (0–500)
|
0 (0–500)
|
0 (0–500)
|
0.336
|
|
Total infusion, mL
|
4845 (3443–6,762)
|
4697 (3475–6502)
|
4883 (3381–6988)
|
0.541
|
|
Saline, mL
|
795 (250–1759)
|
207 (50–700)
|
1150 (700–2050)
|
< 0.001
|
|
D5W, mL
|
770 (312–1493)
|
1220 (752–1896)
|
418 (170–1003)
|
< 0.001
|
|
Other crystalloids, mL
|
2802 (1702–3988)
|
2850 (1894–3896)
|
2759 (1513–4036)
|
0.423
|
|
Hyperglycemiaa
|
374/655 (57.1)
|
161/285 (56.5)
|
213/370 (57.6)
|
0.811
|
|
Hypernatremiab
|
160/735 (21.8)
|
47/321 (14.6)
|
113/414 (27.3)
|
< 0.001
|
|
Blood glucose SD, mg/dLc
|
22 (17–30)
|
21 (16–29)
|
23 (17–30)
|
0.235
|
|
Hypoglycemiad
|
88/833 (10.6)
|
29/359 (8.1)
|
59/474 (12.0)
|
0.053
|
|
Hyponatremiae
|
95/723 (13.1)
|
44/313 (14.1)
|
51/410 (12.4)
|
0.579
|
|
Hyperchloremiaf
|
160/533 (30.0)
|
45/221 (20.4)
|
115/312 (36.9)
|
< 0.001
|
|
AKI diagnosisg
|
377/639 (59.0)
|
165/283 (58.3)
|
212/356 (59.5)
|
0.808
|
|
AKI maximum stageg
| | | |
0.826
|
|
Stage 1
|
204 (54.1)
|
85 (51.5)
|
119 (56.1)
| |
|
Stage 2
|
132 (35.0)
|
61 (37.0)
|
71 (33.5)
| |
|
Stage 3
|
41 (10.9)
|
19 (11.6)
|
22 (10.4)
| |
|
RRT requirementg
|
20 (3.1)
|
6 (2.1)
|
14 (3.9)
|
0.254
|
|
ICU LOS, days
|
4.0 (2.9–6.8)
|
3.9 (2.9–6.4)
|
4.1 (2.9–7.3)
|
0.269
|
|
Hospital LOS, days
|
38 (23–62)
|
40 (24–62)
|
37 (23–62)
|
0.497
|
|
ICU mortality
|
50 (5.9)
|
24 (6.6)
|
26 (5.4)
|
0.557
|
|
Hospital mortality
|
125 (14.8)
|
56 (15.3)
|
69 (14.4)
|
0.769
|
- Data are presented as median (interquartile range) or number (%)
- AKI acute kidney injury, D5W dextrose 5% in water, ICU intensive care unit, LOS length of stay, RRT renal replacement therapy, SD standard deviation
- aPatients with baseline blood glucose ≥ 180 mg/dL were excluded (189 patients)
- bPatients with baseline sodium ≥ 145 mmol/L were excluded (109 patients)
- cPatients with blood glucose < 70 mg/dL or ≥ 180 mg/dL were excluded (200 patients)
- dPatients with baseline blood glucose < 70 mg/dL were excluded (11 patients)
- ePatients with baseline sodium < 135 mmol/L were excluded (121 patients)
- fPatients with baseline chloride ≥ 110 mmol/L were excluded (311 patients)
- gPatients who received a diagnosis of AKI at ICU admission were excluded (205 patients)